Shandong Wit Dyne Health Co.,ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shandong Huate Dayin Health Co., Ltd. (referred to as Huate Dayin) is a listed company on the main board of the Shenzhen Stock Exchange, with its stock abbreviation being Huate Dayin; Stock code: 000915. The total share capital of the company is 234331485 shares, with Shandong Huate Holding Group Co., Ltd. as the largest shareholder and Shandong Provincial State owned Assets Investment Holding Co., Ltd. as the actual controller. The company's main business is pharmaceuticals, while other businesses involve new materials, information, property management, education, and other fields. The company's mission vision is to make millions of Chinese children healthy and strong, and become a leading enterprise in the field of child health and treatment; Adhering to the value concept of "serious work and honest behavior"; Our business philosophy is to focus on medicine, innovate and empower, strengthen, optimize, and expand the children's health industry cluster, and achieve high-quality leapfrog development of the company. The company is a national level comprehensive new drug research and development technology platform industrialization demonstration enterprise, with provincial-level innovation platforms such as "Shandong Children's Drug Preparation Engineering Laboratory", "Shandong Children's Drug Engineering Technology Research Center", "Shandong Enterprise Technology Center", "Shandong Thousand Talents Expert Work Station", "Shandong Postdoctoral Innovation Practice Base", and "Jinan Enterprise Technology Center" Municipal level innovation platforms such as "Weihai Children's Medication Engineering Technology Research Center" and "Weihai Children's Medication New Formulation Key Laboratory". The company has been awarded titles such as "China's Most Valuable Investment Enterprise in the Pharmaceutical Industry", "Top 100 Comprehensive Strength Industrial Enterprises in the Chemical Pharmaceutical Industry", "Excellent Product Brand for Children's Medication in the Chemical Pharmaceutical Industry", and "China Famous Trademark". Multiple products of the company have been listed as national level new products and national key new products, and key pharmaceutical technologies and some products have been included in the application guidelines for the 13th Five Year Plan major special project "Research and Development of Children's Drug Varieties and Key Technologies". Multiple varieties have received significant special support. The pharmaceutical business is the core business of the company, operated by its subsidiary Shandong Dayin Marine Biopharmaceutical Co., Ltd. (referred to as Dayin Pharmaceutical). Da Yin Pharmaceutical is committed to "making millions of Chinese children healthy and strong", and has established the strategic goal of "becoming a leading enterprise in the field of child health and treatment", deeply cultivating the field of child health. In recent years, Dayin Pharmaceutical has won the titles of "magnificent 70 years of striving for a new era", a benchmark enterprise in the pharmaceutical industry for the 70th anniversary of the founding of the People's Republic of China, one of the top 100 comprehensive strength industrial enterprises in the Chinese chemical pharmaceutical industry, and one of the top 100 chemical enterprises in China. IKEX has also been awarded the titles of "China Chemical Pharmaceutical OTC Excellent Product Brand" and "China Chemical Pharmaceutical Industry Children's Medicine Excellent Product Brand". Da Yin Pharmaceutical adheres to the research and development concept of "tailor-made children's drugs" and has established a professional children's drug research institute in China, continuously developing and enriching a series of children's specialized drugs. We have successively obtained approval for platforms such as the "Shandong Enterprise Technology Center", "Shandong Children's Drug Engineering Technology Research Center", "Shandong Children's Drug Preparation Engineering Technology R&D Center", "Shandong Children's Drug Preparation Engineering Laboratory", and "Shandong Postdoctoral Innovation Practice Base". Multiple children's drug use projects have received special support for national major new drug creation during the 13th Five Year Plan. The existing products mainly involve fields such as children's medicine, children's health nutrition food and supplies, forming a children's health industry pattern with "children's health and treatment" as the core. The existing children's drugs mainly include iKeXin (vitamin AD drops (capsule type), GaiDiXin (compound calcium carbonate effervescent granules), IganXin (licorice zinc granules), iDXin vitamin D drops (capsule type), iJiaXin (dextran iron granules), oral rehydration salt powder (III), montmorillonite powder, azithromycin granules, rifaximin dry suspension, and dimercaptosuccinic acid capsules, among which iKeXin is a "well-known trademark in China", For many years, it has been at the leading level of similar products. The Rongcheng production base of Dayin Pharmaceutical covers an area of over 400 acres, designed according to the research and development and production needs of children's specialized drugs, adopts world-class production and testing equipment, and ranks among the top in the Chinese children's pharmaceutical industry in terms of production capacity. Among them, the two production lines of soft capsules and granules have passed the TGA certification in Australia, and the production quality control is in line with international standards. The company's other businesses mainly include new materials, information, property management, education, etc. The new materials business is operated by Shandong Huatezhi New Materials Co., Ltd., engaged in the research and development, growth, and processing of artificial crystals. The information business is operated by Shandong Huate Information Technology Co., Ltd., mainly providing large screen splicing systems, information visualization platform software, and industry solutions for different industries. The property management business is operated by Shandong Huate Property Management Co., Ltd., mainly covering the rental and property management of self owned properties. The education business is operated by Yinan Huate Wolong School, mainly engaged in primary and secondary education. The brand strategy and group operation mode of characteristic operation continuously deepen the strategic layout of the children's health industry, promote the implementation of the strategic goal of "leading enterprises in the field of children's health and treatment", create a children's health industry cluster, and achieve high-quality development of the company. |
| Headquarter | Linyi |
| Establish Date | 6/26/1993 |
| Listed Code | 000915.SZ |
| Listed Date | 6/9/1999 |
| Chairman | Zhu Xiaoping. |
| CEO | Yang Jie. |
| Website | www.sd-wit.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
